查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1416430

生物标记市场报告：2030 年趋势、预测与竞争分析

Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

生物标记趋势和预测

预计到 2030 年，全球生物标记市场将达到 1,105 亿美元，2024 年至 2030 年复合年增长率为 8.8%。该市场的主要驱动因素是对个人化医疗的日益偏好以及政府对生物标记研究和开发的支持不断增加。全球生物标记市场的未来看起来充满希望，诊断、药物发现和开发、个人化医疗和疾病风险评估市场充满机会。

生物标誌物市场洞察

Lucintel 预计，在整个预测期内，消耗品仍将是最大的细分市场。

在这个市场中，诊断在整个预测期内仍将是最大的细分市场。

由于慢性病人口不断增长以及该地区主要参与者的存在，北美将继续成为最大的地区。

常问问题

Q.1 生物标誌物的市场规模有多大？

A1. 到 2030 年，全球生物标记市场预计将达到 1,105 亿美元。

Q.2 生物标记市场的成长预测为何：

A2. 2024年至2030年，全球生物标记市场预计将以8.8%的复合年增长率成长。

Q.3 影响生物标记市场成长的关键因素有哪些：

A3. 该市场的主要驱动力是对个人化医疗的日益偏好以及政府对生物标记研究和开发的支持不断增加。

Q4.市场的主要细分市场是：

A4. 生物标记市场的未来前景广阔，诊断、药物发现和开发、个人化医疗和疾病风险评估市场充满机会。

Q5.市场的主要企业是：

A5. 一些主要的生物标记公司是：

  • Abbott Laboratories
  • QIAGEN
  • PerkinElmer
  • Merck
  • Bio-Rad Laboratories
  • Enzo Biochem
  • Charles River Laboratories
  • Siemens
  • Epistem
  • Eurofins Scientific

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计，在整个预测期内，消耗品仍将是其最大的细分市场。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于慢性病人口不断增长以及该地区主要参与者的存在，北美将继续成为最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球生物标记市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球生物标记市场趋势（2018-2023）与预测（2024-2030）
  • 按产品分類的全球生物标记市场
    • 消耗品
    • 服务
    • 软体
  • 按类型分類的全球生物标记市场
    • 安全生物标记
    • 功效生物标记
    • 预测性生物标记
    • 替代生物标记
    • 动态生物标记
    • 预后生物标记
    • 检验生物标记
  • 按疾病适应症分類的全球生物标记市场
    • 癌症
    • 感染疾病
    • 免疫疾病
    • 神经系统疾病
    • 心血管疾病
    • 其他的
  • 按应用分類的全球生物标记市场
    • 诊断
    • 药物发现与开发
    • 个人化医疗
    • 疾病风险评估
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球生物标记市场
  • 北美生物标誌市场
  • 欧洲生物标记市场
  • 亚太生物标记市场
  • 其他地区生物标记市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球生物标记物市场成长机会（按产品）
    • 按类型分類的全球生物标记市场成长机会
    • 按疾病适应症分類的全球生物标记市场成长机会
    • 全球生物标记物市场成长机会（按应用）
    • 按地区分類的全球生物标记市场成长机会
  • 全球生物标誌物市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球生物标记物市场的产能
    • 全球生物标誌物市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Abbott Laboratories
  • QIAGEN
  • PerkinElmer
  • Merck
  • Bio-Rad Laboratories
  • Enzo Biochem
  • Charles River Laboratories
  • Siemens
  • Epistem
  • Eurofins Scientific
简介目录

Biomarker Trends and Forecast

The future of the global biomarker market looks promising with opportunities in the diagnostic, drug discovery & development, personalized medicine, and disease risk assessment markets. The global biomarker market is expected to reach an estimated $110.5 billion by 2030 with a CAGR of 8.8% from 2024 to 2030. The major drivers for this market are growing preference for personalized medicine and rising government support for biomarker research and development.

A more than 150-page report is developed to help in your business decisions.

Biomarker by Segment

The study includes a forecast for the global biomarker by product, type, disease indication, application, and region.

Biomarker Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Services
  • Software

Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Predictive Biomarkers
  • Surrogate Biomarkers
  • Pharmacodynamics Biomarkers
  • Prognostic Biomarkers
  • Validation Biomarkers

Biomarker Market by Disease Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Cancer
  • Infectious Diseases
  • Immune Disorders
  • Neurological Disorders
  • Cardiovascular Disorders
  • Others

Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Disease Risk Assessment
  • Others

Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biomarker companies profiled in this report include-

  • Abbott Laboratories
  • QIAGEN
  • Perkinelmer
  • Merck
  • Bio-Rad Laboratories
  • Enzo Biochem
  • Charles River Laboratories
  • Siemens
  • Epistem
  • Eurofins Scientific

Biomarker Market Insights

Lucintel forecasts that consumable will remain the largest segment over the forecast period.

Within this market, diagnostic will remain the largest segment over the forecast period.

North America will remain the largest region due to growing number of population with chronic diseases and presence of key players in the region.

Features of the Global Biomarker Market

Market Size Estimates: Biomarker Market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biomarker Market by various segments, such as by product, type, disease indication, application and region in terms of($B).

Regional Analysis: Biomarker Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, disease indications, applications, and regions for the biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the biomarker market size?

Answer: The global biomarker market is expected to reach an estimated $110.5 billion by 2030.

Q.2 What is the growth forecast for biomarker market?

Answer: The global biomarker market is expected to grow with a CAGR of 8.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the biomarker market?

Answer: The major drivers for this market are growing preference for personalized medicine and rising government support for biomarker research and development.

Q4. What are the major segments for biomarker market?

Answer: The future of the biomarker market looks promising with opportunities in the diagnostic, drug discovery & development, personalized medicine, and disease risk assessment markets.

Q5. Who are the key Biomarker Market companies?

Answer: Some of the key biomarker companies are as follows:

  • Abbott Laboratories
  • QIAGEN
  • PerkinElmer
  • Merck
  • Bio-Rad Laboratories
  • Enzo Biochem
  • Charles River Laboratories
  • Siemens
  • Epistem
  • Eurofins Scientific

Q6. Which biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that consumable will remain the largest segment over the forecast period.

Q7. In biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing number of population with chronic diseases and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biomarker market by product (consumables, services, and software), type (safety biomarkers, efficacy biomarkers, predictive biomarkers, surrogate biomarkers, pharmacodynamics biomarkers, prognostic biomarkers, and validation biomarkers), disease indication (cancer, infectious diseases, immune disorders, neurological disorders, cardiovascular disorders, and others), application (diagnostics, drug discovery & development, personalized medicine, disease risk assessment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biomarker Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biomarker Market by Product
    • 3.3.1: Consumables
    • 3.3.2: Services
    • 3.3.3: Software
  • 3.4: Global Biomarker Market by Type
    • 3.4.1: Safety Biomarkers
    • 3.4.2: Efficacy Biomarkers
    • 3.4.3: Predictive Biomarkers
    • 3.4.4: Surrogate Biomarkers
    • 3.4.5: Pharmacodynamics Biomarkers
    • 3.4.6: Prognostic Biomarkers
    • 3.4.7: Validation Biomarkers
  • 3.5: Global Biomarker Market by Disease Indication
    • 3.5.1: Cancer
    • 3.5.2: Infectious Diseases
    • 3.5.3: Immune Disorders
    • 3.5.4: Neurological Disorders
    • 3.5.5: Cardiovascular Disorders
    • 3.5.6: Others
  • 3.6: Global Biomarker Market by Application
    • 3.6.1: Diagnostics
    • 3.6.2: Drug Discovery & Development
    • 3.6.3: Personalized Medicine
    • 3.6.4: Disease Risk Assessment
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biomarker Market by Region
  • 4.2: North American Biomarker Market
    • 4.2.2: North American Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
  • 4.3: European Biomarker Market
    • 4.3.1: European Biomarker Market by Product: Consumables, Services, and Software
    • 4.3.2: European Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
  • 4.4: APAC Biomarker Market
    • 4.4.1: APAC Biomarker Market by Product: Consumables, Services, and Software
    • 4.4.2: APAC Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
  • 4.5: ROW Biomarker Market
    • 4.5.1: ROW Biomarker Market by Product: Consumables, Services, and Software
    • 4.5.2: ROW Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biomarker Market by Product
    • 6.1.2: Growth Opportunities for the Global Biomarker Market by Type
    • 6.1.3: Growth Opportunities for the Global Biomarker Market by Disease Indication
    • 6.1.4: Growth Opportunities for the Global Biomarker Market by Application
    • 6.1.5: Growth Opportunities for the Global Biomarker Market by Region
  • 6.2: Emerging Trends in the Global Biomarker Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biomarker Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomarker Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: QIAGEN
  • 7.3: PerkinElmer
  • 7.4: Merck
  • 7.5: Bio-Rad Laboratories
  • 7.6: Enzo Biochem
  • 7.7: Charles River Laboratories
  • 7.8: Siemens
  • 7.9: Epistem
  • 7.10: Eurofins Scientific